The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

sensysmedical.com

Total Raised

$83.5M

Investors Count

9

Sensys Medical Funding, Sensys Medical Valuation & Sensys Medical Revenue

9 Fundings

Sensys Medical's latest funding round was a Unattributed VC - VII for $11M on August 8, 2006.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

8/8/2006

Unattributed VC - VII

$11M

0

FY undefined

9/15/2003

Unattributed VC - VI

$99M

0

FY undefined

0

7/12/2002

Series D

$99M

0

FY undefined

0

9/8/2000

Unattributed VC - V

$99M

0

FY undefined

0

3/9/1998

Unattributed VC - IV

$99M

0

FY undefined

0

Date

8/8/2006

9/15/2003

7/12/2002

9/8/2000

3/9/1998

Round

Unattributed VC - VII

Unattributed VC - VI

Series D

Unattributed VC - V

Unattributed VC - IV

Amount

$11M

$99M

$99M

$99M

$99M

Investors

Valuation

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

0

0

0

0

Sensys Medical Investors

9 Investors

Sensys Medical has 9 investors. Invesco Private Capital invested in Sensys Medical's Unattributed VC - VII funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

3/9/1998

8/8/2006

5
Other Investors, Series D (2002), Unattributed VC - IV (1998), Unattributed VC - V (2000), Unattributed VC - VII (2006)

Private Equity

Georgia

00/00/0000

00/00/0000

Adams Street Partners

Subscribe to see more

Private Equity

Illinois

00/00/0000

00/00/0000

Alliance Technology Ventures

Subscribe to see more

Venture Capital

Florida

00/00/0000

00/00/0000

Pappas Ventures

Subscribe to see more

Venture Capital

North Carolina

00/00/0000

00/00/0000

Apax Partners

Subscribe to see more

Private Equity

United Kingdom

First funding

3/9/1998

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

8/8/2006

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Adams Street Partners

Alliance Technology Ventures

Pappas Ventures

Apax Partners

Rounds

5
Other Investors, Series D (2002), Unattributed VC - IV (1998), Unattributed VC - V (2000), Unattributed VC - VII (2006)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Private Equity

Private Equity

Venture Capital

Venture Capital

Private Equity

Location

Georgia

Illinois

Florida

North Carolina

United Kingdom

You May Also Like

M
Minomic International

Minomic International specializes in the development and commercialization of diagnostic products.

P
PointCare Technologies

PointCare Technologies is a medical device company building diagnostic devices

L
LifePoint

Lifepoint is a medical technology company developing rapid and cost effective, non-invasive, on-site diagnostic products. The Company has developed and will continue to develop patented, proprietary technologies utilizing saliva as a test specimen to provide blood equivalent diagnostic results without the need for blood or urine.

R
Rafael Medical Technologies

Rafael Medical has developed a novel anchoring system for safely implanting and retrieving a wide range of intra-vascular devices in a minimally invasive manner. Based on the technology, diagnostic and therapeutic devices can be delivered into small and large blood vessels alike by way of a small-sized delivery system. Following the completion of the SafeFlo Filter the company is now developing additional devices geared to the interventional cardiology market.

B
Biopticon

Biopticon Corporation is aimed to develop medical diagnostic devices using laser, photonics and image processing based technologies.

P
Pelikan Technologies

Pelikan Technologies is dedicated to the development of hand-held diagnostic and monitoring devices capable of improving the screening and management of a variety of medical conditions. In addition to diabetes, the company's versatile technology platform has applications across a range of other medical conditions that involve blood screening and monitoring. Point-of-care testing and diagnostic panel test systems also represent markets that can benefit from Pelikan's technology. The Pelikan Sun can improve the quality of life for people with diabetes by combining several of the company's technologies into the most convenient and effective blood glucose self-monitoring device available. Pelikan's line of diabetes management tools will address the pain and inconvenience that has stymied the industry's manufacturers, and plagued people with diabetes, contributing to poor blood glucose monitoring compliance. By targeting these barr

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.